Wu S - Search Results

1

FOXA1 O-GlcNAcylation-mediated transcriptional switch governs metastasis capacity in breast cancer.

Liu Y, Yu K, Kong X, Zhang K, Wang L, Zhang N, Chen Q, Niu M, Li W, Zhong X, Wu S, Zhang J, Liu Y. Liu Y, et al. Among authors: wu s. Sci Adv. 2023 Aug 18;9(33):eadg7112. doi: 10.1126/sciadv.adg7112. Epub 2023 Aug 18. Sci Adv. 2023. PMID: 37595040 Free PMC article.

2

CRM1 is a cellular target of curcumin: new insights for the myriad of biological effects of an ancient spice.

Niu M, Wu S, Mao L, Yang Y. Niu M, et al. Among authors: wu s. Traffic. 2013 Oct;14(10):1042-52. doi: 10.1111/tra.12090. Epub 2013 Jul 31. Traffic. 2013. PMID: 23829533 Free article.

3

Caffeic acid phenethyl ester (CAPE) revisited: Covalent modulation of XPO1/CRM1 activities and implication for its mechanism of action.

Wu S, Zhang K, Qin H, Niu M, Zhao W, Ye M, Zou H, Yang Y. Wu S, et al. Chem Biol Drug Des. 2017 May;89(5):655-662. doi: 10.1111/cbdd.12905. Epub 2017 Mar 8. Chem Biol Drug Des. 2017. PMID: 27863053

4

Discovery of a Low Toxicity O-GlcNAc Transferase (OGT) Inhibitor by Structure-based Virtual Screening of Natural Products.

Liu Y, Ren Y, Cao Y, Huang H, Wu Q, Li W, Wu S, Zhang J. Liu Y, et al. Among authors: wu s, wu q. Sci Rep. 2017 Sep 26;7(1):12334. doi: 10.1038/s41598-017-12522-0. Sci Rep. 2017. PMID: 28951553 Free PMC article.

5

ppGalNAc-T4-catalyzed O-Glycosylation of TGF-β type Ⅱ receptor regulates breast cancer cells metastasis potential.

Wu Q, Zhang C, Zhang K, Chen Q, Wu S, Huang H, Huang T, Zhang N, Wang X, Li W, Liu Y, Zhang J. Wu Q, et al. Among authors: wu s. J Biol Chem. 2021 Jan-Jun;296:100119. doi: 10.1074/jbc.RA120.016345. Epub 2020 Dec 3. J Biol Chem. 2021. PMID: 33234595 Free PMC article.

6

[No title available]

[No authors listed] [No authors listed] PMID: 33434586

7

O-GlcNAcylation promotes topoisomerase IIα catalytic activity in breast cancer chemoresistance.

Liu Y, Yu K, Zhang K, Niu M, Chen Q, Liu Y, Wang L, Zhang N, Li W, Zhong X, Li G, Wu S, Zhang J, Liu Y. Liu Y, et al. Among authors: wu s. EMBO Rep. 2023 Jul 5;24(7):e56458. doi: 10.15252/embr.202256458. Epub 2023 May 30. EMBO Rep. 2023. PMID: 37249035 Free PMC article.

8

Chromatin-associated OGT promotes the malignant progression of hepatocellular carcinoma by activating ZNF263.

Wang L, Li G, Zhou Z, Ge C, Chen Q, Liu Y, Zhang N, Zhang K, Niu M, Li W, Zhong X, Wu S, Zhang J, Liu Y. Wang L, et al. Among authors: wu s. Oncogene. 2023 Jul;42(30):2329-2346. doi: 10.1038/s41388-023-02751-1. Epub 2023 Jun 23. Oncogene. 2023. PMID: 37353617

9

Reversible inhibitor of CRM1 sensitizes glioblastoma cells to radiation by blocking the NF-κB signaling pathway.

Liu X, Tu Y, Wang Y, Zhou D, Chong Y, Shi L, Liu G, Zhang X, Wu S, Li H, Gao S, Niu M, Yu R. Liu X, et al. Among authors: wu s. Cancer Cell Int. 2020 Mar 30;20:97. doi: 10.1186/s12935-020-01186-y. eCollection 2020. Cancer Cell Int. 2020. Retraction in: Cancer Cell Int. 2024 Sep 18;24(1):320. doi: 10.1186/s12935-024-03508-w. PMID: 32256206 Free PMC article. Retracted.

10

Structural bioinformatics-based identification of EGFR inhibitor gefitinib as a putative lead compound for BACE.

Niu M, Hu J, Wu S, Xiaoe Z, Xu H, Zhang Y, Zhang J, Yang Y. Niu M, et al. Among authors: wu s. Chem Biol Drug Des. 2014 Jan;83(1):81-8. doi: 10.1111/cbdd.12200. Chem Biol Drug Des. 2014. PMID: 24516878

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39,376 results

Search Page

Filters